2013 International Conference on Diabetes and Metabolism

> Home > Scientific program

Breakfast symposium1 Sponsored by Lilly

Thursday, 7 November 07:30~08:30 / Convention hall A
Chair: Soon Jib Yoo


	Guntram Schernthaner Rudolfstiftung Hospital, Austria		BS-01 The role of mixtures in the initiation and intensification of insulin treatment for patients with type 2 diabetes

Breakfast symposium2 Sponsored by Novartis

Thursday, 7 November 07:30~08:30 / Convention hall B
Chair: You Hern Ahn


	Mi-Kyung Kim		BS-02 Considerations for managing special populations with diabetes – role of vildagliptin

Breakfast symposium3 Sponsored by Daewoong

Friday, 8 November 07:30~08:30 / Convention hall A
Chair: Hyun Chul Lee


	Sihoon Lee Gachon University, Korea		BS-03 Sitagliptin: optimal choice of DPP-4 inhibitor for patients with T2DM

Breakfast symposium4 Sponsored by Boehringer Ingelheim

Friday, 8 November 07:30~08:30 / Convention hall B
Chair: Hyoung Woo Lee


	Sung Hee Choi		BS-04 Differentiating linagliptin from other DPP-4 inhibitors

Breakfast symposium5 Sponsored by Sanofi Aventis

Friday, 8 November 07:30~08:30 / Convention hall C
Chair: Dong-Sun Kim


	Eun Gyoung Hong Hallym University, Korea		BS-05 What can we do better for the compliance of type 2 diabetic patients

Breakfast symposium6 Sponsored by MSD

Saturday, 9 November 07:30~08:30 / Convention hall A
Chair: Ho Sang Shon


	Hye Jin Yoo Korea University, Korea		BS-06 Efficacy and safety of Sitagliptin in T2DM with CKD and beyond glucose control

Breakfast symposium7 Sponsored by JW Pharmaceutical

Saturday, 9 November 07:30~08:30 / Convention hall B
Chair: Duk Kyu Kim


	Masato Odawara Tokyo Medical University, Japan		BS-07 Pitavastatin and incident T2DM

Luncheon symposium1 Sponsored by Astrazeneca

Thursday, 7 November 12:10~13:10 / Convention hall A,B,C
Chair: Kyu Jeung Ahn


	Richard E. Gilbert University of Toronto, Canada		LS-01 Clinical implications of SAVOR TIMI-53 in type 2 diabetes mellitus

Luncheon symposium2 Sponsored by CJ

Thursday, 7 November 12:10~13:10 / Emerald hall A, B
Chair: Joong Yeol Park


	In-Kyung Jeong Kyung Hee University, Korea		LS-02 Initial therapy with VOGMET® in patients with type 2 diabetes

Luncheon symposium3 Sponsored by ChongKunDang

Thursday, 7 November 12:10~13:10 / Grand ballroom A,B,C
Chair: Sung-Woo Park


	Sin Gon Kim Korea University, Korea		LS-03 Lobeglitazone, a novel PPAR-γ agonist with balanced efficacy and safety

Luncheon symposium4 Sponsored by Sanofi Aventis

Friday, 8 November 12:30~13:30 / Convention hall A
Chair: Yong Seong Kim


	Eun Seok Kang Yonsei University, Korea		LS-04 Rediscovering the one insulin you know: latest update focused on CV risk & new clinical trial

Luncheon symposium5 Sponsored by Takeda

Friday, 8 November 12:30~13:30 / Convention hall B
Chair: Young Seol Kim


	Yukio Tanizawa Yamaguchi University, Japan		LS-05 Refining type 2 diabetes therapy: focusing on ENDURE and EXAMINE trials

Luncheon symposium6 Sponsored by Handok

Friday, 8 November 12:30~13:30 / Convention hall C
Chair: Seong Yeon Kim


	Chang Beom Lee Hanyang University, Korea		LS-06 Intervening early in type 2 diabetes with vildagliptin

Luncheon symposium7 Sponsored by Novonordisk

Friday, 8 November 12:30~13:30 / Emerald hall A, B
Chair: Hyung Joon Yoo


	Chong Hwa Kim Sejong General Hospital, Korea		LS-07 The role of modern insulin in T2DM management (focus on high ratio premixed insulin)

Luncheon symposium8 Sponsored by MSD

Friday, 8 November 12:30~13:30 / Grand ballroom A,B,C
Chair: Yong Ki Kim


	Soo Lim Seoul National University, Korea		LS-08 Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study

Luncheon symposium9 Sponsored by BMS

Saturday, 9 November 12:00~13:00 / Convention hall A,B,C
Chair: Min Young Chung


	Kyu Yeon Hur Sungkyunkwan University, Korea		LS-09 Novel strategy for achieving glucose control in T2DM: Inhibition of renal glucose reabsorption